165 related articles for article (PubMed ID: 30910895)
1. Antifungal Drugs Influence Neutrophil Effector Functions.
Ries F; Alflen A; Aranda Lopez P; Beckert H; Theobald M; Schild H; Teschner D; Radsak MP
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910895
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the in vitro activity of human neutrophils against Aspergillus fumigatus in presence of antifungal and immunosuppressive agents.
Decker C; Wurster S; Lazariotou M; Hellmann AM; Einsele H; Ullmann AJ; Löffler J
Med Mycol; 2018 Jun; 56(4):514-519. PubMed ID: 29420763
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.
Badali H; Khodavaisy S; Fakhim H; de Hoog GS; Meis JF; Chowdhary A
Antimicrob Agents Chemother; 2015 Dec; 59(12):7818-22. PubMed ID: 26369976
[TBL] [Abstract][Full Text] [Related]
4. Interaction of amphotericin B lipid formulations and triazoles with human polymorphonuclear leucocytes for antifungal activity against Zygomycetes.
Simitsopoulou M; Roilides E; Maloukou A; Gil-Lamaignere C; Walsh TJ
Mycoses; 2008 Mar; 51(2):147-54. PubMed ID: 18254752
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs.
Badali H; Mohammadi R; Mashedi O; de Hoog GS; Meis JF
Mycoses; 2015 May; 58(5):303-7. PubMed ID: 25757042
[TBL] [Abstract][Full Text] [Related]
6. Effects of antifungal agents on the function of human neutrophils in vitro.
Roilides E; Walsh TJ; Rubin M; Venzon D; Pizzo PA
Antimicrob Agents Chemother; 1990 Feb; 34(2):196-201. PubMed ID: 2158275
[TBL] [Abstract][Full Text] [Related]
7. Cunninghamella bertholletiae exhibits increased resistance to human neutrophils with or without antifungal agents as compared to Rhizopus spp.
Simitsopoulou M; Georgiadou E; Walsh TJ; Roilides E
Med Mycol; 2010 Aug; 48(5):720-4. PubMed ID: 20100138
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic and immunological interactions of amphotericin B formulations and voriconazole with human neutrophils against mature Scedosporium apiospermum and Fusarium spp. biofilms.
Vikelouda K; Simitsopoulou M; Antachopoulos C; Skoura L; Roilides E
J Antimicrob Chemother; 2023 Apr; 78(4):1076-1083. PubMed ID: 36848199
[TBL] [Abstract][Full Text] [Related]
9. Impact of Antifungal Compounds on Viability and Anti-
Schmidt S; Schubert R; Tramsen L; Lehrnbecher T
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455240
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs.
Shivaprakash MR; Geertsen E; Chakrabarti A; Mouton JW; Meis JF
Mycoses; 2011 Sep; 54(5):e583-9. PubMed ID: 21518026
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of isavuconazole against 208 Aspergillus flavus isolates in comparison with 7 other antifungal agents: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
Rudramurthy SM; Chakrabarti A; Geertsen E; Mouton JW; Meis JF
Diagn Microbiol Infect Dis; 2011 Dec; 71(4):370-7. PubMed ID: 21937186
[
